Literature DB >> 12974748

Population analysis of antiviral T cell responses using MHC class I-peptide tetramers.

H Komatsu1, S Sierro, A V Cuero, P Klenerman.   

Abstract

MHC class I-peptide tetrameric complexes ('tetramers') have revolutionized the study of antiviral CD8+ T cell responses. They allow accurate quantification of immune responses ex vivo independent of function, with high levels of sensitivity. They have revealed unexpectedly large frequencies of 'memory' T cell responses against viruses such as cytomegalovirus (CMV) and Epstein-Barr virus (EBV), and provided information about their phenotypic and functional variation. However, such studies have generally concentrated on limited numbers of individuals analysed in detail. To allow larger population-based studies, we devised a method for tetramer analysis using 50-100 microlitre blood volumes in a 96-well plate format. We adapted this method to study the effect of age on responses in a cohort of nearly 600 individuals to an immunodominant HLA-A2 restricted response to CMV pp65 (NLVPMVATV). We observed the phenomenon of steady 'memory inflation' with age, similar to recently observed longitudinal data from murine studies. These data show that tetramers can be used as population screening tools and could be used to study age-related, geographical or seasonal effects in a number of other viral infections.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12974748      PMCID: PMC1808834          DOI: 10.1046/j.1365-2249.2003.02266.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study.

Authors:  J Olsson; A Wikby; B Johansson; S Löfgren; B O Nilsson; F G Ferguson
Journal:  Mech Ageing Dev       Date:  2000-12-20       Impact factor: 5.432

2.  Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors.

Authors:  G M Gillespie; M R Wills; V Appay; C O'Callaghan; M Murphy; N Smith; P Sissons; S Rowland-Jones; J I Bell; P A Moss
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs.

Authors:  R Holtappels; M F Pahl-Seibert; D Thomas; M J Reddehase
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  T cell selection during the evolution of CD8+ T cell memory in vivo.

Authors:  M F Callan; N Annels; N Steven; L Tan; J Wilson; A J McMichael; A B Rickinson
Journal:  Eur J Immunol       Date:  1998-12       Impact factor: 5.532

5.  Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.

Authors:  G S Ogg; X Jin; S Bonhoeffer; P R Dunbar; M A Nowak; S Monard; J P Segal; Y Cao; S L Rowland-Jones; V Cerundolo; A Hurley; M Markowitz; D D Ho; D F Nixon; A J McMichael
Journal:  Science       Date:  1998-03-27       Impact factor: 47.728

6.  A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response.

Authors:  P R Dunbar; C L Smith; D Chao; M Salio; D Shepherd; F Mirza; M Lipp; A Lanzavecchia; F Sallusto; A Evans; R Russell-Jones; A L Harris; V Cerundolo
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

7.  Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo.

Authors:  M F Callan; L Tan; N Annels; G S Ogg; J D Wilson; C A O'Callaghan; N Steven; A J McMichael; A B Rickinson
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

8.  Analysis of successful immune responses in persons infected with hepatitis C virus.

Authors:  F Lechner; D K Wong; P R Dunbar; R Chapman; R T Chung; P Dohrenwend; G Robbins; R Phillips; P Klenerman; B D Walker
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

9.  Rapid effector function in CD8+ memory T cells.

Authors:  A Lalvani; R Brookes; S Hambleton; W J Britton; A V Hill; A J McMichael
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

10.  Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy.

Authors:  G S Ogg; X Jin; S Bonhoeffer; P Moss; M A Nowak; S Monard; J P Segal; Y Cao; S L Rowland-Jones; A Hurley; M Markowitz; D D Ho; A J McMichael; D F Nixon
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more
  40 in total

1.  Intratumoral Infection with Murine Cytomegalovirus Synergizes with PD-L1 Blockade to Clear Melanoma Lesions and Induce Long-term Immunity.

Authors:  Dan A Erkes; Guangwu Xu; Constantine Daskalakis; Katherine A Zurbach; Nicole A Wilski; Toktam Moghbeli; Ann B Hill; Christopher M Snyder
Journal:  Mol Ther       Date:  2016-06-10       Impact factor: 11.454

2.  Dynamics of killer T cell inflation in viral infections.

Authors:  Dominik Wodarz; Sophie Sierro; Paul Klenerman
Journal:  J R Soc Interface       Date:  2007-06-22       Impact factor: 4.118

3.  Dissecting the requirements for maintenance of the CMV-specific memory T-cell pool.

Authors:  Andrea I Loewendorf; Ramon Arens; Jared F Purton; Charles D Surh; Chris A Benedict
Journal:  Viral Immunol       Date:  2011-07-01       Impact factor: 2.257

Review 4.  Cytomegalovirus memory inflation and immune protection.

Authors:  Luka Cicin-Sain
Journal:  Med Microbiol Immunol       Date:  2019-04-10       Impact factor: 3.402

5.  Sustained CD8+ T-cell responses induced after acute parvovirus B19 infection in humans.

Authors:  Oscar Norbeck; Adiba Isa; Christoph Pöhlmann; Kristina Broliden; Victoria Kasprowicz; Paul Bowness; Paul Klenerman; Thomas Tolfvenstam
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 6.  Cytomegalovirus and immunotherapy: opportunistic pathogen, novel target for cancer and a promising vaccine vector.

Authors:  Michael Quinn; Dan A Erkes; Christopher M Snyder
Journal:  Immunotherapy       Date:  2016-01-20       Impact factor: 4.196

7.  Development of an epitope panel for consistent identification of antigen-specific T-cells in humans.

Authors:  Andreas Fløe; Caroline Løppke; Ole Hilberg; Christian Wejse; Liselotte Brix; Kivin Jacobsen
Journal:  Immunology       Date:  2017-07-03       Impact factor: 7.397

8.  Accurate identification of paraprotein antigen targets by epitope reconstruction.

Authors:  Seshi R Sompuram; Gerassimos Bastas; Kodela Vani; Steven A Bogen
Journal:  Blood       Date:  2007-09-18       Impact factor: 22.113

9.  Immune Protection against Virus Challenge in Aging Mice Is Not Affected by Latent Herpesviral Infections.

Authors:  Thomas F Marandu; Jennifer D Oduro; Lisa Borkner; Iryna Dekhtiarenko; Jennifer L Uhrlaub; Anja Drabig; Andrea Kröger; Janko Nikolich-Zugich; Luka Cicin-Sain
Journal:  J Virol       Date:  2015-09-02       Impact factor: 5.103

10.  Competition between T cells maintains clonal dominance during memory inflation induced by MCMV.

Authors:  Holly Turula; Corinne J Smith; Finn Grey; Katherine A Zurbach; Christopher M Snyder
Journal:  Eur J Immunol       Date:  2013-03-20       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.